Product Information

COMBIGAN 0.2%-0.5% EYE DROPS is a brand product labeled by Allergan, Inc., priced at $39.0886 per ML under NDC 00023921115. Its NADAC has been published 505 times since Dec 21, 2016.

FDA first approved this application on Oct 30, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

COMBIGAN 0.2%-0.5% EYE DROPS

brimonidine tartrate, timolol maleate
$39.0886per ML

Strength

2; 5 mg/mL; mg/mL

Manufacturer

Allergan, Inc.

NDC

00023921115

Classification

Brand

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Effective Date

8/19/2026

Approval Type

New Drug (NDA)

FDA Application

NDA021398

FDA Approved

10/30/2007

TE Code

AB

On Market Since

11/14/2007

Pharmacological Classes

Adrenergic alpha-Agonists
Adrenergic beta-Antagonists
alpha-Adrenergic Agonist
beta-Adrenergic Blocker

Price Statistics

The NADAC for COMBIGAN 0.2%-0.5% EYE DROPS has been published 505 times since Dec 21, 2016, and over the history we have for it it has risen 51.3%. The table below summarizes its recorded NADAC range and movement.

Current price$39.0886 per ML
All-time high$39.3534 (Mar 13, 2024)
All-time low$25.8322 (Dec 21, 2016)
52-week high$39.1760
52-week low$39.0886
Median price$37.3503
Average price$36.0475
Largest weekly change+9.5% (Jan 11, 2017)
Weeks tracked505
Tracking sinceDec 21, 2016

Price History

1W

-0.0%

1M

-0.0%

3M

-0.1%

6M

-0.1%

1Y

-0.2%

3Y

-0.7%

5Y

+4.8%

All

+51.3%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of COMBIGAN 0.2%-0.5% EYE DROPS?

The current National Average Drug Acquisition Cost (NADAC) for COMBIGAN 0.2%-0.5% EYE DROPS, manufactured by Allergan, Inc., is $39.0886 per ML (NDC 00023921115), effective Aug 19, 2026.

How has the price of COMBIGAN 0.2%-0.5% EYE DROPS changed over time?

Over the history we have for it, the NADAC for COMBIGAN 0.2%-0.5% EYE DROPS has risen 51.3%. It has been tracked across 505 weekly CMS publications since Dec 21, 2016.

What are the highest and lowest recorded NADAC prices for COMBIGAN 0.2%-0.5% EYE DROPS?

Since Dec 21, 2016, the NADAC for COMBIGAN 0.2%-0.5% EYE DROPS has ranged from a low of $25.8322 (Dec 21, 2016) to a high of $39.3534 (Mar 13, 2024), with a median of $37.3503 per ML.

Are there cheaper alternatives to COMBIGAN 0.2%-0.5% EYE DROPS?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as COMBIGAN 0.2%-0.5% EYE DROPS in a comparable dosage form, but none are currently priced below it.

Who manufactures COMBIGAN 0.2%-0.5% EYE DROPS?

COMBIGAN 0.2%-0.5% EYE DROPS (NDC 00023921115) is labeled by Allergan, Inc., and CMS classifies it as a brand product.